Table 3. Parvovirus B19 DNA status in a subset of sickle cell anemia (SCA) patients with anti-parvovirus B19 IgM seropositivity ˆ.
Parvovirus B19 IgM Serological markers | Serological status in SCA patients |
Parvovirus B19 DNA (+ve) in SCA patients |
|||||
Steady | Unsteady | Total | Steady | Unsteady | Total | ||
IgM (+) | 7 | 6 | 13 | 0 | 1 | 1 | |
IgM (+) and IgG (+) | 2 | 3 | 5 | 0 | 1 | 1 | |
Total | 9 | 9 | 18 | 0 | 2 (22.2) | 2 (11.1) |
Data are presented as numbers with percentages in parentheses. ˆ None of the 9 IgM seropositive non-SCA serum samples screened was B19 DNA positive. + or ve means positive.